Home
/ Expert Insights

Expert Insights

Explore valuable insights from our thought leaders

Discover our selection of insights below, created to support a better understanding of the diagnosing and monitoring of blood cancers and immune system disorders.

Select content type:
Results Found:
Leverage a dedicated analyzer for Special Protein Assays
Expert Insights
Leverage a dedicated analyzer for Special Protein Assays
Learn how using the the Optilite Analyser as a dedicated analyzer for special protein assays, delivers higher quality results and boosts efficiency in advanced lab workflows.
EXENT Clinical Case Studies
Case Studies
EXENT Clinical Case Studies
Learn more about how the EXENT GAM Assay** enhances monoclonal gammopathy assessment through our clinical case study series.
Advances in Multiple Sclerosis Diagnostic Criteria
Expert Insights
Advances in Multiple Sclerosis Diagnostic Criteria
Listen to how Dr Diana Ferraro, a pioneer in Multiple Sclerosis (MS) diagnosis, has been enhancing her clinical practice by ordering CSF Kappa FLC analysis.
The Choice of Free Light Chain (FLC) Assay matters
Expert Insights
The Choice of Free Light Chain (FLC) Assay matters
The choice of serum free light chain (FLC) assays is critical for clinical laboratories aiming to provide a service clinicians can trust.
ASH 2024 Event Summary
Expert Insights
ASH 2024 Event Summary
Read our comprehensive event summary for the 66th American Society of Hematology annual meeting.
Multiple Myeloma Diagnosis Criteria
Expert Insights
Multiple Myeloma Diagnosis Criteria
Learn more about the multiple myeloma diagnosis criteria that primary care providers should be aware of to avoid end organ damage
Multiple Myeloma Clinical Testing Panels
Expert Insights
Multiple Myeloma Clinical Testing Panels
Explore these case studies to improve clinical decision making for multiple myeloma lab testing. Start improving the multiple myeloma patient journey today.
Multiple Myeloma Relapse Criteria
Expert Insights
Multiple Myeloma Relapse Criteria
Read Binding Site’s overview of multiple myeloma monitoring guidelines when detecting a multiple myeloma relapse, including the use of sFLC blood tests.
The Relevance of Urine Studies
Expert Insights
The Relevance of Urine Studies
Learn why using UPEP tests to assess for light chains in urine delays diagnosis of multiple myeloma. Add an sFLC test to improve time to diagnosis.
Total Light Chain Assays vs Free Light Chain Assays
Expert Insights
Total Light Chain Assays vs Free Light Chain Assays
Learn the difference between the TLC assay and FLC assay to assess for monoclonal proteins, and follow multiple myeloma treatment guidelines.
From Early Signs to Hematology Referrals
Expert Insights
From Early Signs to Hematology Referrals
Suspecting and testing for complex conditions such as monoclonal gammopathies, including Multiple Myeloma can be challenging. Watch this animation on monoclonal gammopathies.
MGUS is of clinical significance
Expert Insights
MGUS is of clinical significance
Discover the clinical significance of MGUS and explore tools to aid in the monitoring of patients with MGUS.
Driving innovation in diagnostics
Expert Insights
Driving innovation in diagnostics
A conversation with Hamid Erfanian as we kick off 2025.
The scientific community trusts Freelite® assays
Expert Insights
The scientific community trusts Freelite® assays
Case studies highlighting why Freelite assays are trusted by the medical community.